 | • レポートコード：MRC2-11QY07035 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は標識ヌクレオチドのグローバル市場について調査・分析したレポートです。種類別（TaqMan対立遺伝子識別、遺伝子チップおよびマイクロアレイ、パイロシーケンシングによるSNP）市場規模、用途別（病院研究所、参照研究所、学術研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別標識ヌクレオチドの競争状況、市場シェア ・世界の標識ヌクレオチド市場：種類別市場規模 2015年-2020年（TaqMan対立遺伝子識別、遺伝子チップおよびマイクロアレイ、パイロシーケンシングによるSNP） ・世界の標識ヌクレオチド市場：種類別市場規模予測 2021年-2026年（TaqMan対立遺伝子識別、遺伝子チップおよびマイクロアレイ、パイロシーケンシングによるSNP） ・世界の標識ヌクレオチド市場：用途別市場規模 2015年-2020年（病院研究所、参照研究所、学術研究所、その他） ・世界の標識ヌクレオチド市場：用途別市場規模予測 2021年-2026年（病院研究所、参照研究所、学術研究所、その他） ・北米の標識ヌクレオチド市場分析：米国、カナダ ・ヨーロッパの標識ヌクレオチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの標識ヌクレオチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の標識ヌクレオチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの標識ヌクレオチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Jena Bioscience、Yumpu、CJ CheilJedang Corporation、Star Lake Bioscience、ThermoFisher Scientific、Meihua Group、F. Hoffmann-La Roche、Biorigin、DSM Nutritional Products、Promega Corporation、Affymetrix、Agilent Technologies、Lallemand、Nanjing BioTogether ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Labeled Nucleotides Market
The global Labeled Nucleotides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Labeled Nucleotides Scope and Market Size
Labeled Nucleotides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Labeled Nucleotides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Labeled Nucleotides market is segmented into
TaqMan Allelic Discrimination
Gene Chips & Microarrays
SNP by Pyrosequencing
Segment by Application, the Labeled Nucleotides market is segmented into
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories
Regional and Country-level Analysis
The Labeled Nucleotides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Labeled Nucleotides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Labeled Nucleotides Market Share Analysis
Labeled Nucleotides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Labeled Nucleotides business, the date to enter into the Labeled Nucleotides market, Labeled Nucleotides product introduction, recent developments, etc.
The major vendors covered:
Jena Bioscience
Yumpu
CJ CheilJedang Corporation
Star Lake Bioscience
ThermoFisher Scientific
Meihua Group
F. Hoffmann-La Roche
Biorigin
DSM Nutritional Products
Promega Corporation
Affymetrix
Agilent Technologies
Lallemand
Nanjing BioTogether
1 Study Coverage
1.1 Labeled Nucleotides Product Introduction
1.2 Market Segments
1.3 Key Labeled Nucleotides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Labeled Nucleotides Market Size Growth Rate by Type
1.4.2 TaqMan Allelic Discrimination
1.4.3 Gene Chips & Microarrays
1.4.4 SNP by Pyrosequencing
1.5 Market by Application
1.5.1 Global Labeled Nucleotides Market Size Growth Rate by Application
1.5.2 Hospital Laboratories
1.5.3 Reference Laboratories
1.5.4 Academic Research Laboratories
1.5.5 Other Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Labeled Nucleotides Market Size, Estimates and Forecasts
2.1.1 Global Labeled Nucleotides Revenue 2015-2026
2.1.2 Global Labeled Nucleotides Sales 2015-2026
2.2 Global Labeled Nucleotides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Labeled Nucleotides Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Labeled Nucleotides Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Labeled Nucleotides Competitor Landscape by Players
3.1 Labeled Nucleotides Sales by Manufacturers
3.1.1 Labeled Nucleotides Sales by Manufacturers (2015-2020)
3.1.2 Labeled Nucleotides Sales Market Share by Manufacturers (2015-2020)
3.2 Labeled Nucleotides Revenue by Manufacturers
3.2.1 Labeled Nucleotides Revenue by Manufacturers (2015-2020)
3.2.2 Labeled Nucleotides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Labeled Nucleotides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Labeled Nucleotides Revenue in 2019
3.2.5 Global Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Labeled Nucleotides Price by Manufacturers
3.4 Labeled Nucleotides Manufacturing Base Distribution, Product Types
3.4.1 Labeled Nucleotides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Labeled Nucleotides Product Type
3.4.3 Date of International Manufacturers Enter into Labeled Nucleotides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Labeled Nucleotides Market Size by Type (2015-2020)
4.1.1 Global Labeled Nucleotides Sales by Type (2015-2020)
4.1.2 Global Labeled Nucleotides Revenue by Type (2015-2020)
4.1.3 Labeled Nucleotides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Labeled Nucleotides Market Size Forecast by Type (2021-2026)
4.2.1 Global Labeled Nucleotides Sales Forecast by Type (2021-2026)
4.2.2 Global Labeled Nucleotides Revenue Forecast by Type (2021-2026)
4.2.3 Labeled Nucleotides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Labeled Nucleotides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Labeled Nucleotides Market Size by Application (2015-2020)
5.1.1 Global Labeled Nucleotides Sales by Application (2015-2020)
5.1.2 Global Labeled Nucleotides Revenue by Application (2015-2020)
5.1.3 Labeled Nucleotides Price by Application (2015-2020)
5.2 Labeled Nucleotides Market Size Forecast by Application (2021-2026)
5.2.1 Global Labeled Nucleotides Sales Forecast by Application (2021-2026)
5.2.2 Global Labeled Nucleotides Revenue Forecast by Application (2021-2026)
5.2.3 Global Labeled Nucleotides Price Forecast by Application (2021-2026)
6 North America
6.1 North America Labeled Nucleotides by Country
6.1.1 North America Labeled Nucleotides Sales by Country
6.1.2 North America Labeled Nucleotides Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Labeled Nucleotides Market Facts & Figures by Type
6.3 North America Labeled Nucleotides Market Facts & Figures by Application
7 Europe
7.1 Europe Labeled Nucleotides by Country
7.1.1 Europe Labeled Nucleotides Sales by Country
7.1.2 Europe Labeled Nucleotides Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Labeled Nucleotides Market Facts & Figures by Type
7.3 Europe Labeled Nucleotides Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Labeled Nucleotides by Region
8.1.1 Asia Pacific Labeled Nucleotides Sales by Region
8.1.2 Asia Pacific Labeled Nucleotides Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Labeled Nucleotides Market Facts & Figures by Type
8.3 Asia Pacific Labeled Nucleotides Market Facts & Figures by Application
9 Latin America
9.1 Latin America Labeled Nucleotides by Country
9.1.1 Latin America Labeled Nucleotides Sales by Country
9.1.2 Latin America Labeled Nucleotides Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Labeled Nucleotides Market Facts & Figures by Type
9.3 Central & South America Labeled Nucleotides Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Labeled Nucleotides by Country
10.1.1 Middle East and Africa Labeled Nucleotides Sales by Country
10.1.2 Middle East and Africa Labeled Nucleotides Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Labeled Nucleotides Market Facts & Figures by Type
10.3 Middle East and Africa Labeled Nucleotides Market Facts & Figures by Application
11 Company Profiles
11.1 Jena Bioscience
11.1.1 Jena Bioscience Corporation Information
11.1.2 Jena Bioscience Description and Business Overview
11.1.3 Jena Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Jena Bioscience Labeled Nucleotides Products Offered
11.1.5 Jena Bioscience Related Developments
11.2 Yumpu
11.2.1 Yumpu Corporation Information
11.2.2 Yumpu Description and Business Overview
11.2.3 Yumpu Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Yumpu Labeled Nucleotides Products Offered
11.2.5 Yumpu Related Developments
11.3 CJ CheilJedang Corporation
11.3.1 CJ CheilJedang Corporation Corporation Information
11.3.2 CJ CheilJedang Corporation Description and Business Overview
11.3.3 CJ CheilJedang Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CJ CheilJedang Corporation Labeled Nucleotides Products Offered
11.3.5 CJ CheilJedang Corporation Related Developments
11.4 Star Lake Bioscience
11.4.1 Star Lake Bioscience Corporation Information
11.4.2 Star Lake Bioscience Description and Business Overview
11.4.3 Star Lake Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Star Lake Bioscience Labeled Nucleotides Products Offered
11.4.5 Star Lake Bioscience Related Developments
11.5 ThermoFisher Scientific
11.5.1 ThermoFisher Scientific Corporation Information
11.5.2 ThermoFisher Scientific Description and Business Overview
11.5.3 ThermoFisher Scientific Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ThermoFisher Scientific Labeled Nucleotides Products Offered
11.5.5 ThermoFisher Scientific Related Developments
11.6 Meihua Group
11.6.1 Meihua Group Corporation Information
11.6.2 Meihua Group Description and Business Overview
11.6.3 Meihua Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Meihua Group Labeled Nucleotides Products Offered
11.6.5 Meihua Group Related Developments
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Corporation Information
11.7.2 F. Hoffmann-La Roche Description and Business Overview
11.7.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.7.4 F. Hoffmann-La Roche Labeled Nucleotides Products Offered
11.7.5 F. Hoffmann-La Roche Related Developments
11.8 Biorigin
11.8.1 Biorigin Corporation Information
11.8.2 Biorigin Description and Business Overview
11.8.3 Biorigin Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biorigin Labeled Nucleotides Products Offered
11.8.5 Biorigin Related Developments
11.9 DSM Nutritional Products
11.9.1 DSM Nutritional Products Corporation Information
11.9.2 DSM Nutritional Products Description and Business Overview
11.9.3 DSM Nutritional Products Sales, Revenue and Gross Margin (2015-2020)
11.9.4 DSM Nutritional Products Labeled Nucleotides Products Offered
11.9.5 DSM Nutritional Products Related Developments
11.10 Promega Corporation
11.10.1 Promega Corporation Corporation Information
11.10.2 Promega Corporation Description and Business Overview
11.10.3 Promega Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Promega Corporation Labeled Nucleotides Products Offered
11.10.5 Promega Corporation Related Developments
11.1 Jena Bioscience
11.1.1 Jena Bioscience Corporation Information
11.1.2 Jena Bioscience Description and Business Overview
11.1.3 Jena Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Jena Bioscience Labeled Nucleotides Products Offered
11.1.5 Jena Bioscience Related Developments
11.12 Agilent Technologies
11.12.1 Agilent Technologies Corporation Information
11.12.2 Agilent Technologies Description and Business Overview
11.12.3 Agilent Technologies Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Agilent Technologies Products Offered
11.12.5 Agilent Technologies Related Developments
11.13 Lallemand
11.13.1 Lallemand Corporation Information
11.13.2 Lallemand Description and Business Overview
11.13.3 Lallemand Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Lallemand Products Offered
11.13.5 Lallemand Related Developments
11.14 Nanjing BioTogether
11.14.1 Nanjing BioTogether Corporation Information
11.14.2 Nanjing BioTogether Description and Business Overview
11.14.3 Nanjing BioTogether Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Nanjing BioTogether Products Offered
11.14.5 Nanjing BioTogether Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Labeled Nucleotides Market Estimates and Projections by Region
12.1.1 Global Labeled Nucleotides Sales Forecast by Regions 2021-2026
12.1.2 Global Labeled Nucleotides Revenue Forecast by Regions 2021-2026
12.2 North America Labeled Nucleotides Market Size Forecast (2021-2026)
12.2.1 North America: Labeled Nucleotides Sales Forecast (2021-2026)
12.2.2 North America: Labeled Nucleotides Revenue Forecast (2021-2026)
12.2.3 North America: Labeled Nucleotides Market Size Forecast by Country (2021-2026)
12.3 Europe Labeled Nucleotides Market Size Forecast (2021-2026)
12.3.1 Europe: Labeled Nucleotides Sales Forecast (2021-2026)
12.3.2 Europe: Labeled Nucleotides Revenue Forecast (2021-2026)
12.3.3 Europe: Labeled Nucleotides Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Labeled Nucleotides Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Labeled Nucleotides Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Labeled Nucleotides Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Labeled Nucleotides Market Size Forecast by Region (2021-2026)
12.5 Latin America Labeled Nucleotides Market Size Forecast (2021-2026)
12.5.1 Latin America: Labeled Nucleotides Sales Forecast (2021-2026)
12.5.2 Latin America: Labeled Nucleotides Revenue Forecast (2021-2026)
12.5.3 Latin America: Labeled Nucleotides Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Labeled Nucleotides Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Labeled Nucleotides Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Labeled Nucleotides Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Labeled Nucleotides Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Labeled Nucleotides Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Labeled Nucleotides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Labeled Nucleotides Market Segments
Table 2. Ranking of Global Top Labeled Nucleotides Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Labeled Nucleotides Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of TaqMan Allelic Discrimination
Table 5. Major Manufacturers of Gene Chips & Microarrays
Table 6. Major Manufacturers of SNP by Pyrosequencing
Table 7. Global Labeled Nucleotides Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Labeled Nucleotides Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Labeled Nucleotides Sales by Regions 2015-2020 (K MT)
Table 10. Global Labeled Nucleotides Sales Market Share by Regions (2015-2020)
Table 11. Global Labeled Nucleotides Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Labeled Nucleotides Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Labeled Nucleotides Sales Share by Manufacturers (2015-2020)
Table 14. Global Labeled Nucleotides Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Labeled Nucleotides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Labeled Nucleotides as of 2019)
Table 16. Labeled Nucleotides Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Labeled Nucleotides Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Labeled Nucleotides Price (2015-2020) (USD/MT)
Table 19. Labeled Nucleotides Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Labeled Nucleotides Product Type
Table 21. Date of International Manufacturers Enter into Labeled Nucleotides Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Labeled Nucleotides Sales by Type (2015-2020) (K MT)
Table 24. Global Labeled Nucleotides Sales Share by Type (2015-2020)
Table 25. Global Labeled Nucleotides Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Labeled Nucleotides Revenue Share by Type (2015-2020)
Table 27. Labeled Nucleotides Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Labeled Nucleotides Sales by Application (2015-2020) (K MT)
Table 29. Global Labeled Nucleotides Sales Share by Application (2015-2020)
Table 30. North America Labeled Nucleotides Sales by Country (2015-2020) (K MT)
Table 31. North America Labeled Nucleotides Sales Market Share by Country (2015-2020)
Table 32. North America Labeled Nucleotides Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Labeled Nucleotides Revenue Market Share by Country (2015-2020)
Table 34. North America Labeled Nucleotides Sales by Type (2015-2020) (K MT)
Table 35. North America Labeled Nucleotides Sales Market Share by Type (2015-2020)
Table 36. North America Labeled Nucleotides Sales by Application (2015-2020) (K MT)
Table 37. North America Labeled Nucleotides Sales Market Share by Application (2015-2020)
Table 38. Europe Labeled Nucleotides Sales by Country (2015-2020) (K MT)
Table 39. Europe Labeled Nucleotides Sales Market Share by Country (2015-2020)
Table 40. Europe Labeled Nucleotides Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Labeled Nucleotides Revenue Market Share by Country (2015-2020)
Table 42. Europe Labeled Nucleotides Sales by Type (2015-2020) (K MT)
Table 43. Europe Labeled Nucleotides Sales Market Share by Type (2015-2020)
Table 44. Europe Labeled Nucleotides Sales by Application (2015-2020) (K MT)
Table 45. Europe Labeled Nucleotides Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Labeled Nucleotides Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Labeled Nucleotides Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Labeled Nucleotides Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Labeled Nucleotides Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Labeled Nucleotides Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Labeled Nucleotides Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Labeled Nucleotides Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Labeled Nucleotides Sales Market Share by Application (2015-2020)
Table 54. Latin America Labeled Nucleotides Sales by Country (2015-2020) (K MT)
Table 55. Latin America Labeled Nucleotides Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Labeled Nucleotides Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Labeled Nucleotides Revenue Market Share by Country (2015-2020)
Table 58. Latin America Labeled Nucleotides Sales by Type (2015-2020) (K MT)
Table 59. Latin America Labeled Nucleotides Sales Market Share by Type (2015-2020)
Table 60. Latin America Labeled Nucleotides Sales by Application (2015-2020) (K MT)
Table 61. Latin America Labeled Nucleotides Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Labeled Nucleotides Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Labeled Nucleotides Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Labeled Nucleotides Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Labeled Nucleotides Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Labeled Nucleotides Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Labeled Nucleotides Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Labeled Nucleotides Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Labeled Nucleotides Sales Market Share by Application (2015-2020)
Table 70. Jena Bioscience Corporation Information
Table 71. Jena Bioscience Description and Major Businesses
Table 72. Jena Bioscience Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Jena Bioscience Product
Table 74. Jena Bioscience Recent Development
Table 75. Yumpu Corporation Information
Table 76. Yumpu Description and Major Businesses
Table 77. Yumpu Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Yumpu Product
Table 79. Yumpu Recent Development
Table 80. CJ CheilJedang Corporation Corporation Information
Table 81. CJ CheilJedang Corporation Description and Major Businesses
Table 82. CJ CheilJedang Corporation Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. CJ CheilJedang Corporation Product
Table 84. CJ CheilJedang Corporation Recent Development
Table 85. Star Lake Bioscience Corporation Information
Table 86. Star Lake Bioscience Description and Major Businesses
Table 87. Star Lake Bioscience Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Star Lake Bioscience Product
Table 89. Star Lake Bioscience Recent Development
Table 90. ThermoFisher Scientific Corporation Information
Table 91. ThermoFisher Scientific Description and Major Businesses
Table 92. ThermoFisher Scientific Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. ThermoFisher Scientific Product
Table 94. ThermoFisher Scientific Recent Development
Table 95. Meihua Group Corporation Information
Table 96. Meihua Group Description and Major Businesses
Table 97. Meihua Group Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Meihua Group Product
Table 99. Meihua Group Recent Development
Table 100. F. Hoffmann-La Roche Corporation Information
Table 101. F. Hoffmann-La Roche Description and Major Businesses
Table 102. F. Hoffmann-La Roche Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. F. Hoffmann-La Roche Product
Table 104. F. Hoffmann-La Roche Recent Development
Table 105. Biorigin Corporation Information
Table 106. Biorigin Description and Major Businesses
Table 107. Biorigin Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Biorigin Product
Table 109. Biorigin Recent Development
Table 110. DSM Nutritional Products Corporation Information
Table 111. DSM Nutritional Products Description and Major Businesses
Table 112. DSM Nutritional Products Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. DSM Nutritional Products Product
Table 114. DSM Nutritional Products Recent Development
Table 115. Promega Corporation Corporation Information
Table 116. Promega Corporation Description and Major Businesses
Table 117. Promega Corporation Labeled Nucleotides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Promega Corporation Product
Table 119. Promega Corporation Recent Development
Table 120. Affymetrix Corporation Information
Table 121. Affymetrix Description and Major Businesses
Table 122. Affymetrix Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Affymetrix Product
Table 124. Affymetrix Recent Development
Table 125. Agilent Technologies Corporation Information
Table 126. Agilent Technologies Description and Major Businesses
Table 127. Agilent Technologies Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Agilent Technologies Product
Table 129. Agilent Technologies Recent Development
Table 130. Lallemand Corporation Information
Table 131. Lallemand Description and Major Businesses
Table 132. Lallemand Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Lallemand Product
Table 134. Lallemand Recent Development
Table 135. Nanjing BioTogether Corporation Information
Table 136. Nanjing BioTogether Description and Major Businesses
Table 137. Nanjing BioTogether Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Nanjing BioTogether Product
Table 139. Nanjing BioTogether Recent Development
Table 140. Global Labeled Nucleotides Sales Forecast by Regions (2021-2026) (K MT)
Table 141. Global Labeled Nucleotides Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Labeled Nucleotides Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Labeled Nucleotides Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Labeled Nucleotides Sales Forecast by Country (2021-2026) (K MT)
Table 145. North America: Labeled Nucleotides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Labeled Nucleotides Sales Forecast by Country (2021-2026) (K MT)
Table 147. Europe: Labeled Nucleotides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Labeled Nucleotides Sales Forecast by Region (2021-2026) (K MT)
Table 149. Asia Pacific: Labeled Nucleotides Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Labeled Nucleotides Sales Forecast by Country (2021-2026) (K MT)
Table 151. Latin America: Labeled Nucleotides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Labeled Nucleotides Sales Forecast by Country (2021-2026) (K MT)
Table 153. Middle East and Africa: Labeled Nucleotides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Labeled Nucleotides Players
Table 158. Labeled Nucleotides Customers List
Table 159. Labeled Nucleotides Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Labeled Nucleotides Product Picture
Figure 2. Global Labeled Nucleotides Sales Market Share by Type in 2020 & 2026
Figure 3. TaqMan Allelic Discrimination Product Picture
Figure 4. Gene Chips & Microarrays Product Picture
Figure 5. SNP by Pyrosequencing Product Picture
Figure 6. Global Labeled Nucleotides Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Laboratories
Figure 8. Reference Laboratories
Figure 9. Academic Research Laboratories
Figure 10. Other Laboratories
Figure 11. Labeled Nucleotides Report Years Considered
Figure 12. Global Labeled Nucleotides Market Size 2015-2026 (US$ Million)
Figure 13. Global Labeled Nucleotides Sales 2015-2026 (K MT)
Figure 14. Global Labeled Nucleotides Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Labeled Nucleotides Sales Market Share by Region (2015-2020)
Figure 16. Global Labeled Nucleotides Sales Market Share by Region in 2019
Figure 17. Global Labeled Nucleotides Revenue Market Share by Region (2015-2020)
Figure 18. Global Labeled Nucleotides Revenue Market Share by Region in 2019
Figure 19. Global Labeled Nucleotides Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Labeled Nucleotides Revenue in 2019
Figure 21. Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Labeled Nucleotides Sales Market Share by Type (2015-2020)
Figure 23. Global Labeled Nucleotides Sales Market Share by Type in 2019
Figure 24. Global Labeled Nucleotides Revenue Market Share by Type (2015-2020)
Figure 25. Global Labeled Nucleotides Revenue Market Share by Type in 2019
Figure 26. Global Labeled Nucleotides Market Share by Price Range (2015-2020)
Figure 27. Global Labeled Nucleotides Sales Market Share by Application (2015-2020)
Figure 28. Global Labeled Nucleotides Sales Market Share by Application in 2019
Figure 29. Global Labeled Nucleotides Revenue Market Share by Application (2015-2020)
Figure 30. Global Labeled Nucleotides Revenue Market Share by Application in 2019
Figure 31. North America Labeled Nucleotides Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Labeled Nucleotides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Labeled Nucleotides Sales Market Share by Country in 2019
Figure 34. North America Labeled Nucleotides Revenue Market Share by Country in 2019
Figure 35. U.S. Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Labeled Nucleotides Market Share by Type in 2019
Figure 40. North America Labeled Nucleotides Market Share by Application in 2019
Figure 41. Europe Labeled Nucleotides Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Labeled Nucleotides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Labeled Nucleotides Sales Market Share by Country in 2019
Figure 44. Europe Labeled Nucleotides Revenue Market Share by Country in 2019
Figure 45. Germany Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Labeled Nucleotides Market Share by Type in 2019
Figure 56. Europe Labeled Nucleotides Market Share by Application in 2019
Figure 57. Asia Pacific Labeled Nucleotides Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Labeled Nucleotides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Labeled Nucleotides Sales Market Share by Region in 2019
Figure 60. Asia Pacific Labeled Nucleotides Revenue Market Share by Region in 2019
Figure 61. China Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Labeled Nucleotides Market Share by Type in 2019
Figure 84. Asia Pacific Labeled Nucleotides Market Share by Application in 2019
Figure 85. Latin America Labeled Nucleotides Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Labeled Nucleotides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Labeled Nucleotides Sales Market Share by Country in 2019
Figure 88. Latin America Labeled Nucleotides Revenue Market Share by Country in 2019
Figure 89. Mexico Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Labeled Nucleotides Market Share by Type in 2019
Figure 96. Latin America Labeled Nucleotides Market Share by Application in 2019
Figure 97. Middle East and Africa Labeled Nucleotides Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Labeled Nucleotides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Labeled Nucleotides Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Labeled Nucleotides Revenue Market Share by Country in 2019
Figure 101. Turkey Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Labeled Nucleotides Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Labeled Nucleotides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Labeled Nucleotides Market Share by Type in 2019
Figure 108. Middle East and Africa Labeled Nucleotides Market Share by Application in 2019
Figure 109. North America Labeled Nucleotides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Labeled Nucleotides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Labeled Nucleotides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Labeled Nucleotides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Labeled Nucleotides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Labeled Nucleotides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Labeled Nucleotides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Labeled Nucleotides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Labeled Nucleotides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Labeled Nucleotides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
安定同位体・安定同位体標識化合物の世界市場（～2026年） Stable isotopes included products containing stable isotopes of carbon, nitrogen, deuterium, oxygen, noble gases and metals. These products are used for numerous applications including biomolecular NMR, quantitative proteomics, metabolic research, and magnetic resonance imaging/spectroscopy and deut…- 安定同位体標識化合物の世界市場（～2026年） Stable isotope labeling market includes those compounds in which one or more atoms are replaced with their respective nonradioactive isotopes that comprise extra neutrons and occur naturally. Market Analysis and Insights: Global Stable Isotope Labeled Compounds Market The global Stable Isotope Label…
- 飼料用ヌクレオチドの世界市場（～2026年） Market Analysis and Insights: Global Feed Nucleotides Market The global Feed Nucleotides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Feed Nucleotides Scope and Market Size Feed Nucleotides market is segmented by Ty…
- 臨床リファレンスラボサービスの世界市場（～2026年） The concept of reference laboratory is a recent phenomenon. Reference laboratories are private as well as commercial facilities that usually perform specialty and high-volume testing routinely. Physicians' offices, clinics, hospitals, government agencies, insurance companies, pharmaceuticals, and bi…
- DNA遺伝子チップの世界市場（～2026年） DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence…